Paper42223907
Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction-associated steatotic liver disease.
Geraci G and 15 others. J Endocrinol Invest, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction-associated steatotic liver disease. Papers, record 42223907. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42223907
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Differential associations of traditional and shape-based adiposity indices with steatosis and fibrosis risk in metabolic dysfunction-associated steatotic liver disease.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adiposity | Major topic |
| Liver Cirrhosis | Major topic |
| Fatty Liver | Major topic |
| Metabolic Diseases | Major topic |
| Humans | |
| Female | |
| Cross-Sectional Studies | |
| Male | |
| Middle Aged | |
| Body Mass Index | |
| Risk Factors | |
| Waist Circumference | |
| Adult | |
| Prognosis |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37156256 | Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment. | Lancet Diabetes Endocrinol | 2023 | https://conductscience.org/library/papers/37156256 | PubMed |
| 2 | 36626630 | The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. | Hepatology | 2023 | https://conductscience.org/library/papers/36626630 | PubMed |
| 3 | 39218222 | Dysglycemia and liver lipid content determine the relationship of insulin resistance with hepatic OXPHOS capacity in obesity. | J Hepatol | 2025 | https://conductscience.org/library/papers/39218222 | PubMed |
| 4 | 40142893 | Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better? | J Clin Med | 2025 | https://conductscience.org/library/papers/40142893 | PubMed |
| 5 | 24586394 | Dynamic association of mortality hazard with body shape. | PLoS One | 2014 | https://conductscience.org/library/papers/24586394 | PubMed |
| 6 | 41547632 | Novel adiposity indices and their role in identifying left ventricular hypertrophy among hypertensive individuals undergoing echocardiography. | Nutr Metab Cardiovasc Dis | 2026 | https://conductscience.org/library/papers/41547632 | PubMed |
| 7 | 32068022 | Metabolic Inflammation-A Role for Hepatic Inflammatory Pathways as Drivers of Comorbidities in Nonalcoholic Fatty Liver Disease? | Gastroenterology | 2020 | https://conductscience.org/library/papers/32068022 | PubMed |
| 8 | 40559092 | Correlations Between Novel Adiposity Indices and Electrocardiographic Evidence of Left Ventricular Hypertrophy in Individuals with Arterial Hypertension. | J Pers Med | 2025 | https://conductscience.org/library/papers/40559092 | PubMed |
| 9 | 41470883 | Refining MASLD Phenotypes: Clinical, Metabolic, and Elastographic Differences Between Adipose Tissue Dysfunction and Obesity-Driven Disease. | Nutrients | 2025 | https://conductscience.org/library/papers/41470883 | PubMed |
| 10 | 40761878 | Beyond BMI: revealing metabolic risk in lean MASLD. | Arch Clin Cases | 2025 | https://conductscience.org/library/papers/40761878 | PubMed |
| 11 | 39315383 | Anthropometric indices in predicting 10-year cardiovascular risk among males and females aged 40-74 years in south and southeast Asia: analysis of 12 WHO STEPS survey data. | Lancet Reg Health Southeast Asia | 2024 | https://conductscience.org/library/papers/39315383 | PubMed |
| 12 | 40049186 | Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. | Lancet | 2025 | https://conductscience.org/library/papers/40049186 | PubMed |
| 13 | 22815707 | A new body shape index predicts mortality hazard independently of body mass index. | PLoS One | 2012 | https://conductscience.org/library/papers/22815707 | PubMed |
| 14 | 40605557 | The Rising Global Burden of MASLD and Other Metabolic Diseases (2000-2021). | United European Gastroenterol J | 2025 | https://conductscience.org/library/papers/40605557 | PubMed |
| 15 | 38851997 | EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). | J Hepatol | 2024 | https://conductscience.org/library/papers/38851997 | PubMed |
| 16 | 37364790 | A multisociety Delphi consensus statement on new fatty liver disease nomenclature. | J Hepatol | 2023 | https://conductscience.org/library/papers/37364790 | PubMed |
| 17 | 39824205 | Definition and diagnostic criteria of clinical obesity. | Lancet Diabetes Endocrinol | 2025 | https://conductscience.org/library/papers/39824205 | PubMed |
| 18 | 39839645 | Correlation between hepatic steatosis severity diagnosed by ultrasound and metabolic indexes in elderly patients with MAFLD. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39839645 | PubMed |
| 19 | 38489523 | AASLD Practice Guideline on blood-based noninvasive liver disease assessment of hepatic fibrosis and steatosis. | Hepatology | 2025 | https://conductscience.org/library/papers/38489523 | PubMed |
| 20 | 35418240 | Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. | Arterioscler Thromb Vasc Biol | 2022 | https://conductscience.org/library/papers/35418240 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42223907
GET https://conductscience.org/api/papers/v1/42223907/references?page=2